STRS Ohio’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$409K Buy
113,500
+8,000
+8% +$28.8K ﹤0.01% 1399
2025
Q1
$315K Hold
105,500
﹤0.01% 1384
2024
Q4
$353K Hold
105,500
﹤0.01% 1326
2024
Q3
$353K Hold
105,500
﹤0.01% 1399
2024
Q2
$349K Buy
105,500
+10,800
+11% +$35.7K ﹤0.01% 1388
2024
Q1
$382K Sell
94,700
-6,000
-6% -$24.2K ﹤0.01% 1362
2023
Q4
$307K Hold
100,700
﹤0.01% 1451
2023
Q3
$302K Hold
100,700
﹤0.01% 1452
2023
Q2
$376K Buy
100,700
+5,500
+6% +$20.5K ﹤0.01% 1393
2023
Q1
$318K Sell
95,200
-32,700
-26% -$109K ﹤0.01% 1485
2022
Q4
$615K Buy
127,900
+36,800
+40% +$177K ﹤0.01% 1197
2022
Q3
$518K Sell
91,100
-3,900
-4% -$22.2K ﹤0.01% 1317
2022
Q2
$674K Sell
95,000
-28,700
-23% -$204K ﹤0.01% 1166
2022
Q1
$893K Buy
123,700
+25,700
+26% +$186K ﹤0.01% 1106
2021
Q4
$876K Buy
98,000
+60,200
+159% +$538K ﹤0.01% 1196
2021
Q3
$1.33M Buy
37,800
+700
+2% +$24.5K 0.01% 938
2021
Q2
$796K Buy
37,100
+28,900
+352% +$620K ﹤0.01% 1341
2021
Q1
$506K Buy
8,200
+4,700
+134% +$290K ﹤0.01% 1566
2020
Q4
$146K Buy
+3,500
New +$146K ﹤0.01% 1812